Luminex Gains Integrated Assay System With $50 Mil. GenturaDx Purchase
This article was originally published in The Gray Sheet
Executive Summary
Deal will enable integration of Luminex’s MultiCode-RTx technology and assays with GenturaDx’s IDbox fully automated, real-time PCR system.
You may also be interested in...
News In Brief
Nanosphere antiplatelet gene test “not approvable”
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.